Clinical follow-up of patients with implantable cardioverter-defibrillator;Acompanhamento clínico de pacientes portadores de cardioversor-desfibrilador implantável

Arquivos Brasileiros de Cardiologia

Volumn 88, Issue 1, 2007, Pages 8-15

  Da Fonseca, Silvia Martelo Souza ^a,b   Belo, Luiz Gustavo ^a   Carvalho, Hécio ^a   Araújo, Nilson ^a   Munhoz, Cláudio ^a   Siqueira, Leonardo ^a   Maciel, Washington ^a   Andréa, Eduardo ^a   Atié, Jacob ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

Appropriate and inappropriate discharges; Implantable cardioverter defibrillator; Ischemic and nonischemic heart disease; Sudden death

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BRUGADA SYNDROME; CHAGAS DISEASE; CHANNELOPATHY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; VALVULAR HEART DISEASE;

ADULT; AGED; AGED, 80 AND OVER; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33947330912     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2007000100002     Document Type: Article

References (32)

1. Myerburg RJ, Castellanos A. Cardiac arrest and sudden cardiac death. In: Braunwald E. Heart Disease: a textbook of cardiovascular medicine. 4th ed. Philadelphia: WB Saunders; 1992. p. 756-789.
2. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med. 1993;119: 1187-97.
3. Myerburg RJ, Interian A Jr, Mitrani A. Frequency of sudden cardiac death and profiles of risk. Am J Cardiol. 1997; 80:10-9.
4. Zipes DP, Wellens HJJ. Sudden cardiac death. Circulation. 1998; 98: 2334-51.
5. Heikki VH, Agustin C, Robert JM. Sudden death due to cardiac arrhythmias. N Engl J Med. 2001: 345: 1473-82.
6. Mark J, Hein JJW. Implantable defibrillators and sudden cardiac death. Circulation. 2004; 109: 2685-91.
7. Priori SG, Aliot E, Blomstrom-Lundqvist C. Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J. 2001; 22: 1374-9.
8. Pratt CM, Moye LA. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med. 1992; 327: 227-33.
9. Greenberg HM, Dwyer EM, Hochman JS. Interaction of ischemia and encainide/flecainide treatment: a proposed mechanism for the increased mortality in CAST I. Br Heart J. 1995; 74: 631-55.
10. Guiraudon G, Fontaine G, Frank R. Encircling endocardial ventriculotomy: a new surgical treatment for life-threatening ventricular tachycardias resistant to medical treatment following myocardial infarction. Ann Thorac. Surg. 1978; 26: 438-44.
11. Mirowski M, Reid PR, Mower MM. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med. 1980; 303: 322-4.
12. Connolly SJ, Hallstrom AP, Cappato R. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J. 2000; 21: 2071-5.
13. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999; 341:1882-90.
14. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. The Cardiac Arrest Study Hamburg (CASH). Circulation. 2000; 102: 748-54.
15. Gregoratos G, Abrams J, Epstein AE. ACC/AHA/NASPE 2002 Guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. Circulation. 2002; 106: 2145-56.
16. Bhandari AK, Rahimtoola SH, Wu D. Frequency and significance of induced sustained ventricular tachycardia or fibrillation 2 weeks after acute myocardial infarction. Am J Cardiol. 1985; 56: 737-42.
17. Iesaka Y, Nogami A, Aonuma K, Nitta J, Chun YH, Fujiwara H, et al. Prognostic significance of sustained monomorphic ventricular tachycardia induced by programmed ventricular stimulation using up to triple extrastimuli in survivors of acute myocardial infarction. Am J Cardiol. 1990; 65: 1057-63.
18. McKenna WJ, Thiene G, Nava A. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J. 1994; 71: 215-8.
19. Teerlink JR, Jalaluddin M, Anderson S. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. Circulation. 2000; 101: 40-6.
20. Pacifico A, Ferlic LL, Cedillo-Salazer FR, Nasir N Jr, Doyle TK, Henry PD. Shocks as predictors of survival in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol. 1999; 34: 204-10.
21. Cruz FE, Maia IG. Arritmias cardíacas na miocardiopatia chagásica. In: Cruz F (org.). Eletrofisiologia clínica e intervencionista das arritmias cardíacas. Rio de Janeiro: Revinter, 1997. p. 197-216.
22. Martinelli Filho M, De Siqueira SF, Moreira H, Fagundes A, Pedrosa A, Nishioka SD, et al. Probability of occurrence of life threatening ventricular arrhythmias in Chagas' disease versus non-Chagas' disease. Pacing Clin Electrophysiol. 2000; 23: 1944-6.
23. Fonarow GC, Feliciano Z, Boyle NG. Improved survival in patients with non ischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator. Am J Cardiol. 2000; 85: 981-5.
24. Domanski MJ, Sakseena S, Epstein AE. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. J Am Coll Cardiol. 1999; 34: 1090-4.
25. Wever EFD, Hauer RNW, Schrijvers G. Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy for postinfarct sudden death survivors: a randomized study. Circulation. 1996; 93: 489-96.
26. Tada H, Ohe T, Yutani C. Sudden death in a patient with apparent idiopathic ventricular tachycardia. Jpn Circ J. 1996; 60: 133-6.
27. Marcus FL. Update of arrhythmogenic right ventricular dysplasia. Card Electrophysiol Rev. 2002; 6: 54-6.
28. Hallstrom AP, McAnulty JH, Wilkoff BL. Patients at lower risk of arrhythmia recurrence: a subgroup in whom implantable defibrillators may not offer benefit. Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Investigators. J Am Coll Cardiol. 2001; 37:1093-9.
29. Kim SG, Hallstrom A, Love JC. Comparison of clinical characteristics and frequency of implantable defibrillator use between randomized patients in the Antiarrhythmics Vs Implantable Defibrillator (AVID) Trial and non randomized registry patients. Am J Cardiol. 1997; 80: 454-7.
30. Anthony CC, Frank IM, Elizabeth AH. Predictors of arrhythmic death and cardiac arrest in the ESVEM trial.Circulation. 1997; 96: 1888-92.
31. Rankovic V, Karha J, Passman R, Kadish AH, Goldberger JJ. Predictors of appropriate implantable cardioverterdefibrillator therapy in patients with idiopathic dilated cardiomyopathy. Am J Cardiol. 2002; 89: 1072-6.
32. Rosenqvist M, Beyer T, Block M, den Dulk K, Minten J, Lindemans F. Adverse events with transvenous implantable cardioverter-defibrillators: a Prospective Multicenter Study. Circulation. 1998; 98: 663-70.